Search

Your search keyword '"Gallardo E"' showing total 1,484 results

Search Constraints

Start Over You searched for: Author "Gallardo E" Remove constraint Author: "Gallardo E"
1,484 results on '"Gallardo E"'

Search Results

157. Milder forms of alpha-sarcoglicanopathies diagnosed in adulthood by NGS analysis

158. Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

159. Isolated girdle weakness: expansion of the phenotypic spectrum of the MERRF 8344A > G mutation of mitochondrial DNA

160. Diagnostic utility of cortactin antibodies in myasthenia gravis

161. PCN157 COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB + IPILIMUMAB VERSUS SUNITINIB IN THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC INTERMEDIATE- OR POOR-RISK RENAL CELL CARCINOMA IN SPAIN

162. mTOR mutations are not associated with shorter PFS and OS in patients treated with mTOR inhibitors

164. Strict trifecta and pentafecta rates in laparoscopic partial nephrectomy: A single centre retrospective study

165. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial

168. DMD - BIOMARKERS: EP.153 Platelet Derived Growth Factor-AA correlates with muscle function tests and quantitative muscle magnetic resonance in dystrophinopathies

170. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

171. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

172. Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and nonobstructive cardiomyopathy

173. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

174. Recent advances in genitourinary tumors: A review focused on biology and systemic treatment

175. Gaia Data Release 1: Testing parallaxes with local Cepheids and RR Lyrae stars

176. Gaia Data Release 1: Testing parallaxes with local Cepheids and RR Lyrae stars

177. Testing parallaxes with local Cepheids and RR Lyrae stars

178. LIMB-GIRDLE MUSCULAR DYSTROPHY I

179. INFLAMMATORY MYOPATHIES

180. Impact of sarcopenia on the global survival of patients with prostate cancer with metastatic debut treated with androgenic-deprivation therapy

181. Characterization of thrombosis risk in patients with cancer

185. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

186. Gaia Data Release 1: Summary of the astrometric, photometric and survey properties

187. The Gaia mission

188. Gaia Data Release 1

189. Expert opinion on first-line therapy in the treatment of castration-resistant prostate cancer

190. Ndufs4 related Leigh syndrome: A case report and review of the literature

191. Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies Common Interferon Signature but Distinct NOS2 Expression

193. SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)

194. Expert Recommendations for First-Line Management of Metastatic Renal Cell Carcinoma in Special Subpopulations

195. Gaia Data Release 1: Summary of the astrometric, photometric, and survey properties

197. SEOM clinical guideline for treatment of kidney cancer (2017)

200. Nintedanib as a new therapeutic agent for Duchenne muscular dystrophy: preclinical in vitro and in vivo studies

Catalog

Books, media, physical & digital resources